Preventive effects of the heparin-coated stent on restenosis in the porcine model

Catheterization and Cardiovascular Interventions

Volumn 48, Issue 3, 1999, Pages 324-330

  Ahn, Young Keun ^a   Jeong, Myung Ho ^a   Kim, Joon Woo ^a   Kim, Seong Hee ^a   Cho, Jang Hyun ^a   Cho, Jeong Gwan ^a   Park, Chang Soo ^a   Juhng, Sang Woo ^a   Park, Jong Chun ^a   Kang, Jung Chaee ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Heparin coated coronary stent; Porcine coronary artery; Restenosis

Indexed keywords

ACETYLSALICYLIC ACID; CYCLINE; HEPARIN; TICLOPIDINE;

ANGIOCARDIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY STENT; DRUG DELIVERY SYSTEM; FOLLOW UP; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTIMA; NONHUMAN; RESTENOSIS; SWINE; THROMBOSIS;

EID: 0032704874     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-726X(199911)48:3<324::AID-CCD20>3.0.CO;2-K     Document Type: Article

References (34)

1. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Ricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D, Teirstein PS, Fish D, Colombo A, Brinker J, Moses J, Shaknovich A, Hirshfield J, Ellis S, Rake R, Goldberg S, for the Stent Restenosis Study Investigators. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501.
2. Serruys PW, de Jaegere PD, Kiemeneij F, Macaya C, Rutsch W, Hndryickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, van der Heuvel P, Delcan J, Morel MA, for the BENESTENT Study Group. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary heart disease. N Engl J Med 1994;331:489-495.
3. De Scheerder I, Wang K, Wilczek K, Meuleman D, Van Amsterdam R, Vogel G, Piessens J, Van de Werf F. Experimental study of thrombogenecity and foreign body reaction induced by heparin-coated coronary stents. Circulation 1997;95:1549-1553.
4. Schwartz RS, Holmes DR, Topol EJ. The restenosis paradigm revised: an alternative proposal for cellular mechanism. J Am Coll Cardiol 1992;20:1284-1293.
5. Fontaine AB, Koelling K, Clay J, Spigos DG, Passos SD, Christoforidis G, Hinkle G, Hill T, Cearlock J, Pozderac R. Decreased platelet adherence of polymer-coated tantalum stents. JVIR 1994;5:567-572.
6. Rensing BJ, Hermans WR, Beatt KJ, Laarman GJ, Suryapranata H, van der Brand M, de Feyter PJ, Serruys PW. Quantitative angiographic assessment of elastic recoil after percutaneous transluminal coronary angioplasty. Am J Cardiol 1990;66:1039-1044.
7. Rensing BJ, Hermans WR, Strauss BH, Serruys PW. Regional difference in elastic recoil after percutaneous transluminal coronary angioplasty: a quantitative angiographic study. J Am Coll Cardiol 1991;17:34B-38B.
8. Currier JW, Faxon DP. After percutaneous transluminal coronary angioplasty: have we been aiming at the wrong target? J Am Coll Cardiol 1995;25:516-520.
9. EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high risk coronary angioplasty. N Engl J Med 1994;330:956.
10. Jeong MH, Park JC, Cha GS, Bae Y, Ahn YG, Park JH, Cho JG, Park JC, Kang JC. The effects of local nitric oxide donor delivery in stented patients. Korean Circulation J 1997;27:592-599.
11. Jeong MH. Local drug delivery in prevention and treatment of coronary restenosis. Korean Circulation J 1998;28:I95-I104.
12. Sarembock IJ, Gertz SD, Gimple LW, Owen RM, Powers ER, Robert WC. Effectiveness of recombinant desulphatohirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. J Am Coll Cardiol 1991;17:251-259.
13. Gellman J, Ezekowitz MD, Saremboch IJ, Azrin MA, Nochomowitz LE, Lerner E, Handenschild CC. Effect of lovastatin on intimal hyperplasia after balloon angioplasty: a study in an atherosclerotic hypercholesterolemic rabbit. J Am Coll Cardiol 1991;17:251-259.
14. Schneider JE, Berk BC, Gravanis MB, Santonian EC, Cipolla GD, Tarazona N, Lassegue B, King SB. Probucol decrease neointimal formation in a swine model of coronary artery balloon injury: a possible role for antioxidants in restenosis. Circulation 1993;88: 628-637.
15. Lichternstein AH, Chobanian AV. Effects of fish oil on atherogenesis in Watanabe heritable hyperlipidemic rabbit. Atherosclerosis 1990;10:597-606.
16. Bairati I, Roy L, Meyer F. Double-blind, randomized, controlled trial of fish oil supplements in prevention of recurrent stenosis after coronary angioplasty. Circulation 1992;85:950-956.
17. Dehmer GJ, Popma JJ, van den Berg EK, Eichhorn EJ, Prowitt JB, Campbell WB, Jennings L, Willerson JT, Schmitz JM. Reduction in the rate of early stenosis after coronary angioplasty by a diet supplemented with α-3 fatty acids. N Engl J Med 1998;319:733-740.
18. Muller DWM. Colchicine and antineoplastic therapy for the prevention of restenosis after percutaneous coronary interventions. J Am Coll Cardiol 1991;17:126B-131B.
19. O'Keefe JH, Mccallister BD, Bateman TM, Kuhnlein DL, Ligon RW, Hartzler GO. Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty. J Am Coll Cardiol 1992;19:1597-1600.
20. Grines CL, Muller DW, Ellis SG, Topol EJ. Colchine angioplasty restenosis trial (CART). Circulation 1989;84:II365.
21. Howell M, Trowbridge R, Foregh M. Effects of delayed angiopeptin treatment on myointima hyperplasia following angioplasty. J Am Coll Cardiol 1991;17:181A.
22. Santoian ED, Schneider JE, Gravanis MB, Hoegh M, Tarazona N, Cipolla GD, King SB. Angiopeptin inhibits intimal hyperplasia after angioplasty in porcine coronary arteries. Circulation 1993;88: 11-14.
23. Cox DA, Anderson PG, Roubin GS, Chou C, Agrawal SK, Cavender JB. Effects of local delivery of methotrexate on neointimal proliferation in stented porcine coronary arteries. Cor Artery Dis 1992;3:237-248.
24. Powell JS, Clozel JP, Muller RK, Kuhn H, Heifti F, Hosang M, Barmgartner HR. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1989;245:186-188.
25. Ferns G, Rainer EW, Sprugel KH, Motani AS, Reidy MA, Ross R. Inhibition of neointimal smooth muscle cell accumulation after angioplasty by an antibody to PDGF. Science 1991;253:1129-1132.
26. Givol D, Yayon A. Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. FASEBJ 1992;6: 3362-3369.
27. Lindner V, Reidy MA. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci 1991;88:3739-3743.
28. Simons M, Edelman E, DeKeyser JL. Antisense c-myb oligonucleotides inhibit arterial smooth muscle cell accumulation in vivo. Nature 1992;359:67-70.
29. Shi Y, Fard A, Galeo A. Transcatheter delivery of c-myc antisense oligomers reduce neointimal formation in a porcine model of coronary artery balloon injury. Circulation 1994;90:944-951.
30. Ohno T, Gordon D, San H, Pompili V, Impenale MJ, Nabel GJ, Nabel EG. Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science 1994;265:781-784.
31. Langer R. New methods of drug delivery. Science 1990;249:1527-1533.
32. Jeong MH, Kang JC, Holmes DR, Schwartz RS. Heparin-loaded fibrin stent prevents acute stent thrombosis. Chonnam J Med Sci 1996;9:173-178.
33. Serruys PW, Emanuelsson H, van der Giessen W, Lunn AC, Kiemeney F, Macaya C, Rutsch W, Heyndrickx G, Suryapranata H, Legrand V, Goy JJ, Materne P, Bonnier H, Morice MC, Fajadet J, Belardi J, Colombo A, Garcia E, Ruygrok P, de Jaegere P, Morel MA. Heparin-coated Palmaz-Schatz stents in human coronary arteries: early outcome of the Benestent-B Pilot Study. Circulation 1996;93:412-422.
34. Serruys PW, van Hout B, Bonnier H, Legrand V, Garcia F, Macaya C, Sousa E, van der Giessen W, Colombo A, Seabra-Gomes R, Kiemeneij F, Ruygrok P, Ormiston J, Emanuelsson H, Fajadet J, Haude M, Klugmann S, Morel MA. Randomized comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease. Lancet 1998;352: 673-681.